TRACON Pharmaceutical (TCON) Enters Oncology Assets Licensing Collaboration with Janssen
Go back to TRACON Pharmaceutical (TCON) Enters Oncology Assets Licensing Collaboration with Janssen| Johnson & Johnson (NYSE: JNJ) | Delayed: 148.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.53 | 52 Week High | $126.07 | |||
| Open | $148.53 | 52 Week Low | $94.28 | |||
| Day High | $148.53 | P/E | 30.88 | |||
| Day Low | $148.53 | EPS | $4.81 | |||
| Volume | 68,415 | |||||
| (NASDAQ: TCON) | Delayed: 1.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.89 | 52 Week High | $12.49 | |||
| Open | $1.89 | 52 Week Low | $4.00 | |||
| Day High | $1.89 | P/E | N/A | |||
| Day Low | $1.89 | EPS | $0.00 | |||
| Volume | 1,711 | |||||
